Keywords
Ovarian cancer
Inflammation
Angiogenesis
Submitted : 2022-02-08
Accepted : 2022-02-23
Published : 2022-03-10
Abstract
Ovarian malignancies are the most complicated type among all gynecological cancers. Their etiology is yet unknown; however, they are a heterogeneous, rapidly growing, and very fatal group of cancers. Chronic inflammation and angiogenesis appear to have major contributions in the development and progression of ovarian malignancies. Angiogenesis and inflammation are involved in the pathogenesis of ovarian cancer. Vitamin D3 (VitD3) has shown to have anti-inflammatory and anti-angiogenic properties in different types of cancers. The anti-inflammatory and anti-angiogenesis effects of VitD3 on ovarian cancer are investigated in this review.
References
Coburn S, Bray F, Sherman M, et al., 2017, International Patterns and Trends in Ovarian Cancer Incidence, Overall and by Histologic Subtype. International Journal of Cancer, 140(11): 2451-2460.
Jayson GC, Kohn EC, Kitchener HC, et al., 2014, Ovarian Cancer. The Lancet, 384(9951): 1376-1388.
Soslow RA, 2008, Histologic Subtypes of Ovarian Carcinoma: An Overview. International Journal of Gynecological Pathology, 27(2): 161-74.
Maccio A, Madeddu C, 2012, Inflammation and Ovarian Cancer. Cytokine, 58(2): 133-147.
Shivappa N, Hebert JR, Rosato V, et al., 2016, Dietary Inflammatory Index and Ovarian Cancer Risk in a Large Italian Case-Control Study. Cancer Causes & Control, 27(7): 897-906.
Heyden E, Wimalawansa S, 2018, Vitamin D: Effects on Human Reproduction, Pregnancy, and Fetal Well-Being. The Journal of Steroid Biochemistry and Molecular Biology, 180: 41-50.
Veldurthy V, Wei R, Oz L, et al., 2016, Vitamin D, Calcium Homeostasis and Aging. Bone Research, 4(1): 1-7.
Umar M, Sastry KS, Chouchane AI, 2018, Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies. International Journal of Molecular Sciences, 19(6): 1618.
Eisman J, MacIntyre I, Martin T, et al., 1979, 1,25-Dihydroxyvitamin-D Receptor in Breast Cancer Cells. The Lancet, 314(8156-8157): 1335-1336.
Makishima M, Lu TT, Xie W, et al., 2002, Vitamin D Receptor as an Intestinal Bile Acid Sensor. Science, 296(5571): 1313-1316.
Nian D, Li Z, Sun J, et al., 2021, Effect of 1,25 (OH) 2D3 on Experimental Autoimmune Neuritis and Its Mechanism. Trends in Immunotherapy, 5(2.1): 42-50.
Abdollahi E, Rezaee SA, Saghafi N, et al., 2020, Evaluation of the Effects of 1,25 vitamin D3 on Regulatory T Cells and T Helper 17 Cells in Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss. Current Molecular Pharmacology, 13(4): 306-317.
Li N, Saghafi N, Ghaneifar Z, et al., 2021, Evaluation of the Effects of 1,25VitD3 on Inflammatory Responses and IL-25 Expression. Frontiers in Genetics, 12: 779494.
Abdollahi E, Saghafi N, Rezaee SAR, et al., 2020, Evaluation of 1, 25 (OH) 2D3 Effects on FOXP3, ROR-?t, GITR, and CTLA-4 Gene Expression in PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss. Iranian Biomedical Journal, 24(5): 295.
Illescas-Montes R, Melguizo-Rodríguez L, Ruiz C, et al., 2019, Vitamin D and Autoimmune Diseases. Life Sciences, 233: 116744.
Deuster E, Jeschke U, Ye Y, et al., 2017, Vitamin D and VDR in Gynecological Cancers – A Systematic Review. International Journal of Molecular Sciences, 18(11): 2328.
Liu Y, Li C, Chen P, et al., 2013, Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian Cancer: A Meta-Analysis. PLoS One, 8(6): e66716.
Yin L, Grandi N, Raum E, et al., 2011, Meta-Analysis: Circulating Vitamin D and Ovarian Cancer Risk. Gynecologic Oncology, 121(2): 369-375.
Savant SS, Sriramkumar S, O’Hagan HM, 2018, The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer. Cancers, 10(8): 251.
Jia D, Nagaoka Y, Katsumata M, et al., 2018, Inflammation is a Key Contributor to Ovarian Cancer Cell Seeding. Scientific Reports, 8(1): 1-7.
Pannunzio A, Coluccia M, 2018, Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature. Pharmaceuticals, 11(4): 101.
Deng L, Feng D, Ling B, 2020, Cyclooxygenase-2 Promotes Ovarian Cancer Cell Migration and Cisplatin Resistance Via Regulating Epithelial Mesenchymal Transition. Journal of Zhejiang University-SCIENCE B, 21(4): 315-326.
El-Sharkawy A, Malki A, 2020, Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications. Molecules, 25(14): 3219.
Thill M, Woeste A, Reichert K, et al., 2015, Vitamin D Inhibits Ovarian Cancer Cell Line Proliferation in Combination with Celecoxib and Suppresses Cyclooxygenase-2 Expression. Anticancer Research, 35(2): 1197-1203.
Kavandi L, Collier MA, Nguyen H, et al., 2012, Progesterone and Calcitriol Attenuate Inflammatory Cytokines CXCL1 and CXCL2 in Ovarian and Endometrial Cancer Cells. Journal of Cellular Biochemistry, 113(10): 3143-3152.
Trujillo JA, Sweis RF, Bao R, et al., 2018, T cell-Inflamed Versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunology Research, 6(9): 990-1000.
Muralidhar S, Filia A, Nsengimana J, et al., 2019, Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity. Cancer Research, 79(23): 5986-5998.
Luke JJ, Bao R, Sweis RF, et al., 2019, WNT/?-catenin Pathway Activation Correlates with Immune Exclusion Across Human Cancers. Clinical Cancer Research, 25(10): 3074-3083.
Zhang X, Li P, Bao J, et al., 2005, Suppression of Death Receptor-Mediated Apoptosis by 1, 25-Dihydroxyvitamin D3 Revealed by Microarray Analysis. Journal of Biological Chemistry, 280(42): 35458-35468.
Mantell D, Owens P, Bundred N, et al., 2000, 1?, 25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo. Circulation Research, 87(3): 214-220.
Pendas-Franco N, García JM, Pena C, et al., 2008, DICKKOPF-4 is Induced by TCF/?-Catenin and Upregulated in Human Colon Cancer, Promotes Tumour Cell Invasion and Angiogenesis and Is Repressed by 1?, 25-Dihydroxyvitamin D3. Oncogene, 27(32): 4467-4477.
Maj E, Filip-Psurska B, Milczarek M, et al., 2018, Vitamin D Derivatives Potentiate the Anticancer and Anti-Angiogenic Activity of Tyrosine Kinase Inhibitors in Combination with Cytostatic Drugs in an A549 Non-Small Cell Lung Cancer Model. International Journal of Oncology, 52(2): 337-366.
Bao B-Y, Yao J, Lee Y-F, 2006, 1?, 25-Dihydroxyvitamin D 3 Suppresses Interleukin-8-Mediated Prostate Cancer Cell Angiogenesis. Carcinogenesis, 27(9): 1883-1893.
Ben-Shoshan M, Amir S, Dang DT, et al., 2007, 1?, 25-Dihydroxyvitamin D3 (Calcitriol) Inhibits Hypoxia-Inducible Factor-1/Vascular Endothelial Growth Factor Pathway in Human Cancer Cells. Molecular Cancer Therapeutics, 6(4): 1433-1439.